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ABSTRACT
Heavy veal calves (4–6 mo old) often develop problems 
with insulin sensitivity. This could lead to metabolic 
disorders and impaired animal growth performance. 
Studies in various animal species have shown that the 
supplementation of short-chain fructo-oligosaccharides 
(scFOS) can improve insulin sensitivity. We therefore 
studied the effects of scFOS supplementation on insulin 
sensitivity in heavy veal calves. Forty male Holstein-
Friesian calves (BW = 190 ± 2.9 kg; age = 162 ± 1.4 d 
at the start of the trial) were fed either a control milk 
replacer (MR) diet or a diet in which one-third of the 
lactose was replaced by glucose, fructose, or glycerol 
for 10 wk prior to the start of the trial. At the start of 
the trial, calves were subjected to a frequently sampled 
intravenous glucose tolerance test to assess whole-body 
insulin sensitivity (muscle and hepatic insulin sensitiv-
ity). Calves within each dietary treatment group were 
ranked based on their insulin sensitivity value. Half of 
the calves received scFOS (12 mg/kg of BW) with the 
MR for 6 wk (supplementation was equally distributed 
over the insulin sensitivity range). Subsequently, a sec-
ond frequently sampled intravenous glucose tolerance 
test was conducted to assess the effect of scFOS. In 
addition, fasting plasma levels of glucose, insulin, tri-
glycerides, and cholesterol were determined to calculate 
the quantitative insulin sensitivity check index and 
triglyceride: high -density lipoprotein cholesterol ratio 
(fasting indicators of insulin sensitivity). Whole-body 
insulin sensitivity was low at the start of the trial and 
remained low in all groups [1.0 ± 0.1 and 0.8 ± 0.1 
(mU/L)−1 · min−1 on average, respectively]. Supplemen-
tation of scFOS did not improve insulin sensitivity in 
any of the treatment groups. The quantitative insulin 
sensitivity check index and the triglyceride: high -density 
lipoprotein cholesterol ratio also did not differ between 
scFOS and non-scFOS calves and averaged 0.326 ± 
0.003 and 0.088 ± 0.004, respectively, at the end of the 
trial. We conclude that scFOS supplementation does 
not improve insulin sensitivity in heavy veal calves re-
gardless of the carbohydrate composition of the MR. 
This is in contrast to other animals (e.g., dogs and 
horses), where scFOS supplementation did improve 
insulin sensitivity. The absence of an effect of scFOS 
might be related to the dosage or to metabolic differ-
ences between ruminants and nonruminants. Increasing 
evidence indicates that dietary interventions in veal 
calves have little or no effect on insulin sensitivity, pos-
sibly because of low levels of insulin sensitivity.
Key words: veal calf, milk replacer, fructo-
oligosaccharides, insulin sensitivity
Short Communication
Veal calves are fed milk replacer (MR) and solid feed 
(roughage and concentrates) and are exposed to large 
quantities of lactose and fat via the MR. Prolonged 
high intakes of MR can induce problems with glucose 
homeostasis and insulin sensitivity in veal calves. These 
problems have been identified in heavy veal calves (4–6 
mo), characterized by a high incidence of hyperglyce-
mia, hyperinsulinemia, and glucosuria (Hostettler-Allen 
et al., 1994; Hugi et al., 1997) and insulin resistance 
(Pantophlet et al., 2016a). In a recent study, we found 
that calves raised on a lactose MR diet, or diets in 
which one-third of the lactose was replaced by glucose, 
fructose, or glycerol, did not differ in insulin sensitiv-
ity and that insulin sensitivity was low (Pantophlet 
et al., 2016c). This could lead to metabolic disorders 
and impaired animal growth performance. Therefore, 
prevention strategies must be developed. Various 
animal studies have shown that dietary short-chain 
fructo-oligosaccharide (scFOS) supplementation can 
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help prevent problems and improve whole-body insulin 
sensitivity (i.e., muscle and hepatic insulin sensitivity). 
In obese dogs and horses, for example, supplementa-
tion of dietary scFOS for a period of 6 wk increased 
insulin sensitivity (Respondek et al., 2008; Respondek 
et al., 2011). In young veal calves (<3 mo old), supple-
mentation of scFOS for 10 wk did not improve insulin 
sensitivity or glucose homeostasis (Pantophlet et al., 
2016b). In older veal calves (10–13 wk old), however, 
scFOS supplementation did improve postprandial glu-
cose homeostasis (Kaufhold et al., 2000). A decrease 
in postprandial response for glucose was observed, but 
not for insulin. Mechanisms were not reported. It is not 
clear whether the improved glucose homeostasis dur-
ing scFOS supplementation in older calves is related to 
changes in insulin sensitivity. Therefore, the objective 
of this study was to assess the effects of scFOS supple-
mentation on insulin sensitivity in heavy veal calves.
Forty male Holstein-Friesian calves (BW = 190 ± 
2.9 kg; age = 162 ± 1.4 d; mean ± SEM) were housed 
at the research facility of the Department of Animal 
Sciences at Wageningen University (Wageningen, the 
Netherlands). Calves were housed in groups (5 calves/
pen) except for the first and last week of the trial. 
During these periods calves were housed individually 
in metabolic cages (0.80 × 1.8 m). Experimental pro-
cedures complied with the Dutch Law on Experimental 
Animals and the ETS123 (Council of Europe 1985 and 
the 86/609/EEC Directive) and were approved by the 
Animal Care and Use Committee of Wageningen Uni-
versity. Prior to the start of the trial, the calves were 
fed either a control MR diet (n = 10) or diets in which 
one-third of the lactose in the MR was replaced by 
isoenergetic amounts of glucose (Tereos Syral, Marckol-
sheim, France; n = 10), fructose (Tate and Lyle Europe, 
Boleraz, Slovakia; n = 10), or glycerol (Triconor Distri-
bution BV, Soest, the Netherlands; n = 10) for 10 wk. 
All calves remained on their diets throughout the trial. 
A detailed description of the diets and feeding strategy 
is provided elsewhere (Pantophlet et al., 2016c). In 
short, calves were fed MR and solid feed (20% wheat 
straw and 80% concentrates) twice a day, at 0630 and 
1530 h. The MR was fed on an individual basis (BW 
was measured weekly), and solid feed was provided per 
pen during group housing and per individual calf when 
the calves were housed in metabolic cages. Calves had 
ad libitum access to water. Whole-body insulin sensi-
tivity was assessed at the start and the end of the trial. 
The start values were used to assign calves to scFOS or 
no scFOS within each dietary treatment group (i.e., n 
= 5 for scFOS; n = 5 for no scFOS). The calves were 
ranked to evenly distribute the supplementation scFOS 
over the insulin sensitivity range in each group. The 
scFOS were added to the MR at a dose of 12 mg/kg 
of BW for 6 wk. At the end of the 6-wk period, whole-
body insulin sensitivity was assessed again to study 
the effect of scFOS supplementation. One calf in the 
glucose group was excluded from all measurements due 
to ruminal drinking.
Whole-body insulin sensitivity was assessed using the 
frequently sampled intravenous glucose tolerance test. 
A detailed description of this experimental procedure is 
provided elsewhere (Pantophlet et al., 2016c). In short, 
a central venous catheter (Careflow, Becton Dickinson, 
Franklin Lakes, NJ) was inserted in the jugular vein 
for glucose and insulin infusion and blood sampling. 
Calves were fasted to achieve a steady glucose turn-
over rate before the test. At t = 0 min, an intravenous 
glucose bolus of 0.3 g/kg of BW (20% glucose solu-
tion; B. Braun, Oss, the Netherlands) was administered 
within 2 min followed by an intravenous insulin bolus 
of 0.03 IU/kg of BW (100 IU/mL solution; Insuman 
Rapid, Sanofi-Aventis, Gouda, the Netherlands) at t 
= 20 min (administered within 1 min). Blood samples 
were collected at t = −8, −4, 2, 4, 6, 8, 10, 12, 14, 16, 
19, 22, 25, 30, 35, 40, 50, 60, 75, 90, 120, 150, and 180 
min relative to the glucose bolus. The samples were 
centrifuged (1,516 × g for 10 min), and plasma was 
harvested for the analysis of plasma glucose and insulin 
concentrations. In addition, plasma triglycerides and 
high-density lipoprotein (HDL) cholesterol concentra-
tions were analyzed in the fasting plasma sample col-
lected at t = −8 min (at the start and the end of the 
trial). Whole-body insulin sensitivity was calculated 
according to Bergman’s minimal model approach us-
ing MinMod Millennium (version 6.0.2; MinMod Inc., 
Los Angeles, CA). In addition, another index of insulin 
sensitivity, the quantitative insulin sensitivity index 
(QUICKI; Muniyappa et al., 2008), was calculated 
from the fasting plasma glucose and insulin concentra-
tions. Also, clean urine was quantitatively collected for 
a period of 5 and 3 d at the start and the end of the 
trial, respectively. A detailed description of the urine 
collection procedure is provided elsewhere (Pantophlet 
et al., 2016c). Urinary glucose and plasma glucose, 
triglycerides, and HDL cholesterol were measured on 
a Roche-Hitachi modular automatic analyzer (Roche 
Diagnostics, Basel, Switzerland) using enzymatic colo-
rimetric assays. The within- and between-run coeffi-
cients of variation were ≤2% for all analyses. Insulin 
was measured using a bovine ELISA kit (Mercodia, 
Uppsala, Sweden). The within- and between-run coef-
ficients of variation were ≤5.6 and 8.2%, respectively.
Data were analyzed using SPSS (version 22; IBM, 
Armonk, NY). The effect of scFOS on whole-body in-
sulin sensitivity, QUICKI, triglyceride: HDL cholesterol 
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ratio, fasting plasma glucose and insulin, and urinary 
glucose excretion was tested by ANOVA using the 
GLM (Univariate) procedure. The overall effect of sc-
FOS and the within-treatment effect (i.e., within the 
several diets) were tested. Supplementation with scFOS 
(i.e., scFOS vs. non-scFOS calves) was used as a factor, 
and calf was the experimental unit. The final values 
(i.e., measured at the end of the trial) were used as 
dependent variables, with their respective initial val-
ues as covariates. For the overall effects an scFOS × 
dietary treatment interaction was included. P-values < 
0.05 were considered significant.
The average daily BW gain, measured over the whole 
trial period, was on average 1.19 ± 0.02 kg/d and did 
not differ between dietary treatments or scFOS treat-
ment. Feed refusal was negligible throughout the trial. 
Whole-body insulin sensitivity calculated using Min-
Mod Millennium was low at the start of the trial (it did 
not differ between scFOS and non-scFOS calves) and 
remained low until the end [1.0 ± 0.1 and 0.8 ± 0.1 
(mU/L)−1 · min−1 on average at the start and the end 
of the trial, respectively]. Supplementation of scFOS 
did not improve insulin sensitivity (P = 0.324; Table 
1). During the trial, fasting plasma glucose levels de-
Table 1. Insulin sensitivity, triglyceride:high-density lipoprotein (HDL) cholesterol ratio, fasting glucose, and 
insulin and urinary glucose excretion (mean ± SEM) at the end of the trial in veal calves fed a control milk 
replacer (n = 10) or a milk replacer in which one-third of the lactose was replaced by isoenergetic amounts of 







−4, (mU/L) −1 min−1    
 Overall 0.79 ± 0.14 0.89 ± 0.13 0.324 0.463
 Control 0.74 ± 0.14 1.01 ± 0.34 0.291  
 Glucose 0.71 ± 0.27 0.83 ± 0.10 0.852  
 Fructose 1.36 ± 0.39 1.00 ± 0.27 0.505  
 Glycerol 0.44 ± 0.10 0.62 ± 0.10 0.130  
QUICKI        
 Overall 0.324 ± 0.004 0.329 ± 0.005 0.434 0.734
 Control 0.308 ± 0.011 0.323 ± 0.011 0.558  
 Glucose 0.320 ± 0.005 0.342 ± 0.007 0.063  
 Fructose 0.340 ± 0.013 0.325 ± 0.003 0.807  
 Glycerol 0.324 ± 0.006 0.331 ± 0.007 0.639  
Triglyceride:HDL cholesterol ratio    
 Overall 0.087 ± 0.006 0.090 ± 0.007 0.191 0.288
 Control 0.089 ± 0.012 0.106 ± 0.012 0.090  
 Glucose 0.095 ± 0.009 0.103 ± 0.026 0.160  
 Fructose 0.067 ± 0.016 0.079 ± 0.003 0.482  
 Glycerol 0.091 ± 0.013 0.077 ± 0.009 0.430  
Fasting glucose, mmol/L        
 Overall 5.1 ± 0.1 5.0 ± 0.1 0.100 0.069
 Control 5.0 ± 0.2 5.1 ± 0.2 0.574  
 Glucose 4.8 ± 0.2 5.1 ± 0.1 0.295  
 Fructose 5.3 ± 0.1 5.1 ± 0.2 0.295  
 Glycerol 5.4 ± 0.1 5.1 ± 0.1 0.171  
Fasting insulin, mU/L        
 Overall 15.5 ± 2.2 12.7 ± 1.3 0.204 0.397
 Control 23.2 ± 9.4 16.1 ± 3.8 0.467  
 Glucose 16.0 ± 1.7 9.6 ± 1.9 0.062  
 Fructose 10.6 ± 1.7 13.1 ± 1.0 0.629  
 Glycerol 15.5 ± 2.2 12.7 ± 1.3 0.615  
Urinary glucose excretion, g/d        
 Overall 48.5 ± 14.2 31.8 ± 8.6 0.243 0.435
 Control 49.5 ± 21.7 37.3 ± 10.9 0.438  
 Glucose 126.9 ± 20.3 83.4 ± 15.8 0.298  
 Fructose 7.0 ± 2.7 7.7 ± 4.8 0.670  
 Glycerol 3.0 ± 2.5 4.2 ± 2.5 0.877  
1ISminmod = insulin sensitivity derived from MinMod Millenium (MinMod Inc., Los Angeles, CA); QUICKI = 
quantitative insulin sensitivity check index.
2Half of the calves in each treatment group (n = 5) received 12 mg of short-chain fructo-oligosaccharides 
(scFOS)/kg of BW with the milk replacer for 6 wk.
3Interation P-value = P-value of scFOS × dietary treatment interaction.
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creased by 9%, whereas insulin levels increased by 25% 
(5.9 ± 0.1 mmol/L and 14.1 ± 1.3 mU/L on average, 
respectively, at the end of the trial). Short-chain fructo-
oligosaccharides did not affect fasting plasma glucose 
or insulin levels (P = 0.100 and 0.204 for glucose and 
insulin, respectively; Table 1). The QUICKI, derived 
from the fasting plasma and insulin levels, did not im-
prove by the supplementation of scFOS (P = 0.434; 
Table 1). Fasting plasma triglyceride decreased by 20%, 
whereas HDL cholesterol levels increased by 35% (0.109 
± 0.005 and 0.741 ± 0.054 mmol/L, respectively, at 
the end of the trial). The triglyceride: HDL cholesterol 
ratio (fasting indicator of insulin resistance) did not 
improve by the supplementation of scFOS (P = 0.191; 
Table 1). Urinary glucose excretion, which is a result of 
hyperglycemia (occurs when the threshold for glucose 
reabsorption is exceeded), was substantially higher (P 
< 0.01) in control and glucose calves compared with 
fructose and glycerol calves. Glucose excretion did not 
differ between scFOS and non-scFOS calves (P = 0.243; 
Table 1).
In contrast with observations in other species (Re-
spondek et al., 2008, 2011), scFOS supplementation did 
not improve insulin sensitivity in veal calves. It cannot 
be excluded that the absence of an effect of scFOS is 
related to the administered dose, which in this study 
was based on meta-analysis of the dose–response ef-
fect of scFOS supplementation on feed conversion ratio 
in veal calves (Kaufhold et al., 2000; Tai et al., 2009; 
Grand et al., 2013), because of the lack of data on 
the dose–response effect of scFOS supplementation on 
insulin sensitivity. We assumed that the feed conversion 
ratio is related to glucose utilization and thus might 
be related to insulin sensitivity. Based on BW, the 
administered dose in this trial was approximately 3 to 
4 times lower than in previous studies in horses (in 
which scFOS improved insulin sensitivity; Respondek 
et al., 2011) and veal calves (in which scFOS improved 
glucose homeostasis; Kaufhold et al., 2000). Future 
studies need to focus on the dose–response effect of 
scFOS supplementation on insulin sensitivity in veal 
calves, if any. In some nonruminant species (e.g., dogs 
and horses), scFOS supplementation has been shown 
to improve insulin sensitivity. The absence of an effect 
of scFOS might therefore also be related to metabolic 
differences between ruminants and nonruminants. In 
calves, insulin sensitivity rapidly decreases during the 
first months of life (Stanley et al., 2002) independently 
of the weaning strategy (Stanley et al., 2002; Panto-
phlet et al., 2016b), and although differences in glucose 
homeostasis are observed as a result of dietary interven-
tions, generally little to no effect on insulin sensitivity 
is found (Bach et al., 2013; Pantophlet et al., 2016a, c). 
This might be related to the ontogenetic development 
of calves, as ontogenetic ruminants absorb little glucose 
from the intestinal tract and therefore may not have 
the genetic capacity to rapidly deal with large amounts 
of glucose. Consequently, absorbing large quantities 
of glucose from the MR disturbs glucose homeostasis 
in heavy veal calves. Mechanistic insight into species 
differences in the regulation of insulin sensitivity is 
required to obtain progress in this field. In conclusion, 
supplementation of scFOS to the MR did not improve 
insulin sensitivity in heavy veal calves.
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